Ophthalmology Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Opinion Article - Ophthalmology Case Reports (2024) Volume 8, Issue 5

Managing Dry Eye with Therapeutic Eye Patches

Fatemeh Hosseini*

Department of Ophthalmology, Tehran University of Medical Sciences, Iran

*Corresponding Author:
Fatemeh Hosseini
Department of Ophthalmology
Tehran University of Medical Sciences, Iran
E-mail: fhosseini@tums.ac.ir

Received: 03-Oct-2024, Manuscript No. OER-24-149611; Editor assigned: 05-Oct-2024, Pre QC No. OER-24-149611(PQ); Reviewed: 19-Oct-2024, QC No. OER-24-149611; Revised: 25-Oct-2024, Manuscript No. OER-24-149611 (R); Published: 30-Oct-2024, DOI: 10.35841/oer-8.5.234

Citation: Hosseini F. Managing Dry Eye with Therapeutic Eye Patches. Ophthalmol Case Rep. 2024; 8(5):234

Visit for more related articles at Ophthalmology Case Reports

Introduction

Dry eye disease (DED) is a common condition that affects millions of people worldwide. Characterized by inadequate tear production or excessive tear evaporation, it results in inflammation, irritation, and potential damage to the surface of the eye. The condition can significantly impact quality of life, causing discomfort, blurry vision, and sensitivity to light. While artificial tears and medications are commonly prescribed, therapeutic eye patches have emerged as an effective non-invasive solution for managing dry eye symptoms. These patches provide protection, promote healing, and offer relief from dryness by maintaining a moist and stable environment around the eye [1].

Dry eye disease is caused by either insufficient tear production (aqueous-deficient dry eye) or excessive tear evaporation (evaporative dry eye). The condition is often linked to age, hormonal changes, environmental factors, or underlying health issues such as autoimmune diseases. Left untreated, dry eye can lead to chronic discomfort, inflammation, and damage to the corneal surface, resulting in visual disturbances. Traditional treatments, including artificial tears and ointments, only provide temporary relief. In more severe cases, therapeutic eye patches have proven to be an effective adjunct therapy by helping to maintain moisture and reduce the evaporation of tears from the eye surface [2].

Therapeutic eye patches are designed to create a closed or semi-closed environment that helps retain moisture, reducing tear evaporation and allowing the ocular surface to recover. These patches work by providing continuous hydration to the eye, preventing desiccation of the corneal surface, which is crucial for healing. For patients with severe dry eye, especially those with difficulty maintaining a stable tear film, these patches offer more prolonged relief than artificial tears alone [3].

There are several types of therapeutic eye patches designed for managing dry eye, each with unique properties. Moisture chamber goggles are a popular option that encloses the eye in a humid environment, which significantly reduces tear evaporation and provides sustained moisture. These goggles can be worn overnight, making them ideal for patients who suffer from nocturnal dry eye. Another common option is hydrogel patches, which are applied directly to the closed eyelid and provide cooling relief while enhancing moisture retention [4].

Moisture retention is the cornerstone of managing dry eye with therapeutic patches. Some advanced patches use hydrogel technology to lock in moisture and gradually release it over time. Hydrogel patches not only provide a moist environment for the eye but also have a cooling effect that can reduce inflammation and discomfort. The soft, flexible material conforms to the eye's surface, ensuring a secure fit and enhanced protection. Other types of patches may incorporate silicone materials, which are breathable and allow oxygen to reach the eye while still maintaining a barrier against moisture loss [5].

Many patients with dry eye experience worsened symptoms during sleep, as the eyes tend to dry out overnight. This is especially common in individuals who sleep with their eyes partially open, a condition known as nocturnal lagophthalmos. Therapeutic eye patches designed for overnight use are an excellent solution to this problem. These patches help seal the eye, creating a moisture-rich environment that prevents nighttime tear evaporation. By wearing the patches during sleep, patients wake up with significantly reduced dryness and discomfort, improving the overall management of their condition [6].

Chronic dry eye often leads to inflammation of the ocular surface, which can further disrupt tear production and exacerbate symptoms. Therapeutic eye patches help break this cycle by providing a stable, moist environment that reduces inflammation. Some patches are even infused with anti-inflammatory agents such as hyaluronic acid or corticosteroids to promote healing and relieve irritation. The cooling effect of certain patches, especially hydrogel-based ones, can also soothe the eye and provide relief from burning or itching, which are common complaints in dry eye patients [7].

For many people with dry eye, environmental factors such as wind, smoke, and dry indoor air can worsen symptoms. Therapeutic eye patches serve as a physical barrier, shielding the eye from these irritants and helping to maintain a stable tear film. This is particularly beneficial for individuals who work in environments with harsh conditions, such as air-conditioned offices or windy outdoor areas. Moisture chamber goggles, in particular, are effective at blocking environmental triggers while also preventing tear evaporation, making them a versatile tool for managing dry eye both indoors and outdoors [8].

A stable tear film is essential for maintaining ocular surface health and comfort. In patients with dry eye, the tear film becomes unstable, leading to dry spots on the cornea and subsequent irritation. Therapeutic eye patches help restore tear film stability by creating a humid environment that allows the tear film to spread more evenly across the eye's surface. This not only relieves symptoms but also supports the regeneration of damaged corneal cells. The sustained moisture provided by these patches can promote long-term healing and improve the overall function of the tear film [9].

One of the advantages of therapeutic eye patches is their ease of use and convenience, which enhances patient compliance. For patients who need long-term management of dry eye, these patches offer a non-invasive, low-maintenance solution. They can be used daily or as needed, depending on the severity of symptoms. Some patches are designed for overnight use, while others can be worn during the day without interfering with vision or comfort. This flexibility makes therapeutic eye patches a viable option for a wide range of patients, including those with busy lifestyles who may struggle to adhere to more time-consuming treatments [10].

Conclusion

Therapeutic eye patches offer an innovative and effective way to manage dry eye disease, especially in patients who experience persistent dryness or difficulty maintaining tear film stability. By providing a moist and protective environment, these patches support corneal healing, reduce inflammation, and protect the eye from environmental irritants. Whether used overnight or during the day, therapeutic eye patches are a valuable addition to the arsenal of treatments available for managing dry eye, improving patient comfort and enhancing quality of life.

References

  1. Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocular Surface. 2017;15(3):276-83.

    2. Indexed at, Google Scholar, Cross Ref

  2. Stapleton F, Alves M, Bunya VY, et al. Tfos dews ii epidemiology report. Ocular Surface. 2017;15(3):334-65.

    3. Indexed at, Google Scholar, Cross Ref

  3. Jain D. In vitro model for Fuchs Endothelial Dystrophy and its effects on corneal endothelial cells.

    4. Indexed at, Google Scholar

  4. Raviv T. Dysfunctional Tear Syndrome: New Strategies for Diagnosis and Treatment.

    5. Indexed at, Google Scholar, Cross Ref

  5. Nassiri N, Zhou XY, Rodriguez Torres Y, et al. Current and emerging therapy of dry eye disease. Part B: non-pharmacological modalities. Expert Rev Ophthalmol. 2017;12(4):299-312.

    6. Indexed at, Google Scholar, Cross Ref

  6. McCabe E, Narayanan S. Advancements in anti-inflammatory therapy for dry eye syndrome. Am J Optom. 2009;80(10):555-66.

    7. Indexed at, Google Scholar, Cross Ref

  7. Sullivan DA, Rocha EM, Aragona P, et al. TFOS DEWS II sex, gender, and hormones report. Ocular Surface. 2017;15(3):284-333.

    8. Indexed at, Google Scholar, Cross Ref

  8. Calonge M, Pinto-Fraga J, González-García MJ, et al. Effects of the external environment on dry eye disease. Int Ophthalmol Clin. 2017;57(2):23-40.

    9. Indexed at, Google Scholar, Cross Ref

  9. Messmer EM. Pathophysiology of dry eye disease and novel therapeutic targets. Exp Eye Res. 2022;217:108944.

    10. Indexed at, Google Scholar, Cross Ref

  10. Ervin AM, Law A, Pucker AD. Punctal occlusion for dry eye syndrome. Cochrane Database Syst Rev. 2017(6).

    11. Indexed at, Google Scholar, Cross Ref

Get the App